CE Mark for Symplicity Spyral renal dernervation system-Medtronic
Medtronic, Inc.has announced on 5 December 2013 CE Mark (Conformit� Europ�enne) in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its highly flexible 4 Fr multi-electrode Symplicity Spyral catheter and Symplicity (G3) radio frequency (RF) generator. This new system is designed to significantly reduce ablation time and provide ease of deliverability during renal denervation procedures for patients with Uncontrolled Hypertension. The multi-electrode Spyral system leverages the proprietary Symplicity treatment algorithm and Symplicity helical ablation pattern responsible for the clinical success and unmatched safety profile of the single-electrode Symplicity renal denervation system.
The Symplicity renal denervation system is available for investigational use only in the United States.